Physitrack PLC — Transactions under Share Buy-back Programme
Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, it has undertaken the following share repurchase transactions during the period 21 September 2026 to 25 September 2026 (the "Period").
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 21 September 2026 - 25 September 2026 | 6,708 | 8.7487 | 58,686.19 | 45,390 | 16,260,766 | 0.2784% |
Individual transactions
The following is a detailed breakdown of the transactions on each trading day during the Period:
| Date | Quantity | Average price (SEK) |
| 2026-09-21 | 2,000 | 8.77 |
| 2026-09-22 | 958 | 8.78 |
| 2026-09-23 | 1,500 | 8.78 |
| 2026-09-24 | 1,500 | 8.5933 |
| 2026-09-25 | 750 | 8.90 |
The buy-back programme is conducted within the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. All transactions are executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer: | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument/ISIN: | Ordinary shares / GB00BYX22590 |
| 3. Trading venue: | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency: | SEK |
| 5. Purpose of buy-back: | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker: | Pareto Securities (non-discretionary mandate |
This announcement contains information that Physitrack PLC is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact persons set out above, at 11:30 CEST on 28 September 2026.
About Physitrack
Physitrack plc (Nasdaq First North: PTRK), d/b/a Physitrack Group, is a global provider of AI-powered software for healthcare and workplace wellbeing, delivering personalized, scalable tools through its Physitrack and Champion Health platforms.
Physitrack enables healthcare providers to deliver and manage app-guided physical and occupational services with AI powered workflows with measurable patient outcomes and built-in billing and reimbursement support, while Champion Health provides businesses with mental, physical, and financial wellbeing solutions to support workforce health and productivity.
Physitrack Group’s solutions seamlessly integrate with existing systems, including EMR/EHR/PMS connectivity, and are trusted by more than 110,000 providers and organizations across 170+ countries. For more information, visit www.physitrackgroup.com and follow us on LinkedIn and X.
Enquiries regarding this announcement should be addressed to:
Corporate Contact:
Henrik Molin, CEO and co-founder, Physitrack
ir@physitrack.com
media@physitrack.com
+1 415 230 0414